chitosan has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmonsif, DA; Dief, AE; El Azhary, NM; El-Fetiany, OS; Youssef, AEH | 1 |
| Chen, C; Gan, W; He, R; Hou, H; Li, J; Lian, Z; Peng, B; Tang, P; Xu, Q; Ye, Z; Zhang, G; Zhang, L | 1 |
2 other study(ies) available for chitosan and Demyelinating Diseases
| Article | Year |
|---|---|
LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats.
Topics: Administration, Intranasal; Animals; Ataxia; Caspase 3; Chitosan; Demyelinating Diseases; Disease Models, Animal; Drug Carriers; Drug Compounding; Ethidium; Gene Expression Regulation; Male; Membrane Proteins; Myelin Basic Protein; Myelin Sheath; Nanoparticles; Nerve Tissue Proteins; Neuroprotective Agents; Nucleus Raphe Magnus; Rats; Rats, Wistar; Remyelination; RNA, Small Interfering; Stereotaxic Techniques | 2019 |
Chitooligosaccharide Inhibits Scar Formation and Enhances Functional Recovery in a Mouse Model of Sciatic Nerve Injury.
Topics: Animals; Axons; Cell Death; Chitin; Chitosan; Cicatrix; Collagen; Demyelinating Diseases; Disease Models, Animal; Fibroblasts; Male; Mice, Transgenic; Nerve Regeneration; Oligosaccharides; Recovery of Function; Reflex; Sciatic Nerve; Time Factors | 2016 |